| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,181 |
8,254 |
$1.37M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,728 |
10,946 |
$1.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,347 |
4,681 |
$767K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,446 |
5,270 |
$566K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,659 |
3,133 |
$449K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,299 |
1,699 |
$417K |
| 71045 |
Radiologic examination, chest; single view |
1,651 |
1,421 |
$212K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,165 |
1,922 |
$133K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,446 |
1,028 |
$100K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,618 |
1,419 |
$94K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,622 |
1,392 |
$91K |
| H0038 |
Self-help/peer services, per 15 minutes |
546 |
302 |
$72K |
| 36415 |
Collection of venous blood by venipuncture |
15,610 |
13,236 |
$62K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
706 |
666 |
$54K |
| 80053 |
Comprehensive metabolic panel |
8,273 |
7,058 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,048 |
8,490 |
$43K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
550 |
418 |
$37K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
519 |
469 |
$35K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
86 |
76 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
868 |
724 |
$28K |
| 80050 |
General health panel |
238 |
209 |
$28K |
| 71046 |
Radiologic examination, chest; 2 views |
240 |
223 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
537 |
512 |
$19K |
| 87503 |
|
706 |
666 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,156 |
1,085 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
374 |
329 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
278 |
177 |
$14K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
128 |
108 |
$13K |
| 87428 |
|
452 |
430 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
132 |
119 |
$13K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
150 |
142 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,494 |
1,327 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
58 |
52 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
424 |
409 |
$7K |
| 84484 |
|
1,397 |
824 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
419 |
376 |
$7K |
| 80061 |
Lipid panel |
771 |
699 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
221 |
203 |
$6K |
| 99221 |
|
15 |
14 |
$6K |
| 87276 |
|
418 |
386 |
$5K |
| 90791 |
Psychiatric diagnostic evaluation |
43 |
37 |
$5K |
| 83735 |
|
1,342 |
1,116 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
433 |
378 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
525 |
440 |
$5K |
| 81003 |
|
3,319 |
2,323 |
$5K |
| 83690 |
|
1,374 |
1,182 |
$4K |
| 87275 |
|
418 |
386 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
72 |
44 |
$4K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
67 |
28 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
273 |
257 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
664 |
574 |
$3K |
| 83880 |
|
129 |
111 |
$3K |
| 83605 |
|
301 |
214 |
$1K |
| 84100 |
|
595 |
500 |
$1K |
| 81001 |
|
679 |
563 |
$1K |
| 85730 |
|
497 |
407 |
$1K |
| 85610 |
|
630 |
520 |
$1K |
| 80305 |
|
117 |
101 |
$1K |
| 82746 |
|
163 |
132 |
$965.09 |
| 82607 |
|
142 |
120 |
$921.71 |
| 82728 |
|
146 |
119 |
$826.35 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
24 |
20 |
$811.39 |
| 85379 |
|
192 |
144 |
$788.98 |
| 86140 |
|
226 |
207 |
$782.80 |
| 80076 |
|
158 |
133 |
$752.93 |
| 85027 |
|
182 |
165 |
$734.93 |
| 82150 |
|
219 |
176 |
$614.41 |
| 83550 |
|
125 |
106 |
$496.85 |
| 87040 |
|
105 |
57 |
$479.68 |
| 92551 |
|
45 |
40 |
$478.12 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
145 |
98 |
$415.99 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$392.92 |
| 82803 |
|
54 |
30 |
$374.46 |
| 83540 |
|
125 |
106 |
$374.38 |
| 81025 |
|
56 |
51 |
$369.91 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
159 |
140 |
$285.60 |
| 83655 |
|
12 |
12 |
$157.80 |
| 82550 |
|
34 |
25 |
$76.25 |
| 84703 |
|
12 |
12 |
$75.20 |
| 82553 |
|
33 |
24 |
$71.35 |
| 85652 |
|
44 |
40 |
$66.04 |
| 85014 |
|
12 |
12 |
$30.84 |
| 85018 |
|
12 |
12 |
$30.84 |
| 0011A |
|
18 |
13 |
$23.04 |
| 90677 |
|
12 |
12 |
$0.05 |
| 90686 |
|
201 |
191 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
45 |
43 |
$0.00 |